Recurrence of medulloblastoma: Violation of Collins' Law after two decades

Surgical Neurology

Volumn 47, Issue 6, 1997, Pages 571-574

  Friedberg, Marc H ^a,b   David, Odile ^a   Adelman, Lester S ^a   Heilman, Carl B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Collins' Law; medulloblastoma recurrence

Indexed keywords

CYCLOPHOSPHAMIDE; VINCRISTINE;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CHILD; CRANIOTOMY; HUMAN; MALE; MEDULLOBLASTOMA; TUMOR RECURRENCE;

CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; MODELS, THEORETICAL; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; TIME FACTORS;

EID: 0031006679     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-3019(96)00387-4     Document Type: Article

References (20)

1. Belza MG, Donaldson SS, Seinberg GK, Cox RS, Cogen PH. Medulloblastoma: freedom from relapse longer than eight years - a therapeutic cure? J Neurosurg 1991;75:575-82.
2. Bloom HJG, Wallace ENK, Henk JM. The treatment and prognosis of medulloblastoma in children. AJR 1969;105:43-62.
3. Brown WD, Tavare CJ, Sobel EL, Gilles FH. Medulloblastoma and Collins' Law: A critical review of the concept of a period of risk for tumor recurrence and patient survival. Neurosurgery 1995;6:1093-6.
4. Burger PC, Scheithauer BW. Atlas of tumor pathology: tumors of the central nervous system. Washington, D.C.: Armed Forces Institute of Pathology, 1994:205-17, 442.
5. Collins VP. Wilms' tumor: its behavior and prognosis. J LA State Med Soc 1955;107:474-80.
6. Dell S, Cohen M, Kushner M. Period of risk hypothesis after prophylactic radiotherapy. Child's Brain 1978;8: 589-92.
7. Gilles GF, Sobel EL, Leviton A, Tavare CJ, Hedley-Whyte ET, The Childhood Brain Tumor Consortium. Histologic feature reliability in childhood neural tumors. J Neuropathol Experimental Neurol 1994;53: 559-71.
8. Harisiadis L, Chang CH. Medulloblastoma in children: a correlation between staging and results of treatment, Int J Rad One Biol Phys 1977;2:833-41.
9. Hirsh JF, Renier D, Czernichow P, Benveniste L, Pierre-Kahn A. Medulloblastoma in childhood. Survival and functional results. Acta Neurochir 1979;48: 1-15.
10. King GA, Sagerman RH. Late recurrence in medulloblastoma AJR 1975;123:7-12.
11. Kleriga E, Sher JH, Nallainathan SK, Stein SC, Sacher M. Development of cerebellar malignant astrocytoma at a site of a medulloblastoma treated 11 years earlier. J Neurosurg 1978;49:445-9.
12. Kramer S. Radiation therapy in the management of brain tumors in children. Ann NY Acad Sci 1969;159: 571-84.
13. Latchaw JP, Hahn JF, Moylan DJ, Humphries R, Mealey J. Medulloblastoma: period of risk reviewed. Cancer 1985;55:186-9.
14. Lefkowitz IB, Packer RJ, Ryan SG, Shah N, Alavi J, Rorke LB, Sutton LN, Schut L. Late recurrence of primitive neuroectodermal tumor/medulloblastoma. Cancer 1988;62:826-30.
15. Mealey J, Hall PV. Medulloblastoma in children: survival and treatment. J Neurosurg 1977;46:56-64.
16. Park TS, Hoffman HJ, Hendrick EB, Humphreys RP, Becker LE. Medulloblastoma: clinical presentation and management. Experience at the Hospital for Sick Children, Toronto, 1950-1980. J Neurosurg 1983;58:543-52.
17. Pearl GS, Mirra SS, Miles ML. Glioblastoma multiforme occurring 13 years after treatment of a medulloblastoma. Neurosurgery 1980;6:546-51.
18. Quest DO, Brisman R, Antunes JL, Housepian EM. Period of risk for recurrence in medulloblastoma. J Neurosurg 1978;48:159-63.
19. Raimondi AJ, Tomita T. Medulloblastoma in childhood: comparative results of partial and total resection. Child's Brain 1979;5:310-28.
20. Rosenstock JG. Medulloblastoma, thyroid carcinoma, and recurrent brain tumor in the same patient. Med Ped Onc 1982;10:161-4.